Zobrazeno 1 - 10
of 80
pro vyhledávání: '"G. Esquerdo"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elisabeth Pérez-Ruiz, Ana Jaén, M. J. Sotelo, I. Blancas, M. M. Gordon, M. Fontanillas, N. M. Jáñez, Cesar Mendiola, V. Conde, J. S. Bofill, J. Lao, J. M. Baena-Cañada, Andrés García-Palomo, E. Martínez, Josefina Cruz, J. Bayo, F. Carabantes, Jose Juan Illarramendi, Manuel Ruiz-Borrego, G. Esquerdo
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname
This study aimed to describe the efficacy of fulvestrant 500 mg in postmenopausal women with estrogen receptor (ER)-positive advanced/metastatic breast cancer who had disease progression after receiving anti-estrogen therapy in clinical practice, get
Autor:
V. Conde, N. M. Jáñez, J. S. Bofill, J. L. Bayo, E. Martínez, J.J. Illarramendi, I. Blancas, M. Fontanillas, M. Ruiz-Borrego, Andrés García-Palomo, J. M. Baena-Cañada, M. J. Sotelo, J. Lao, C. Mendiola, J. Cruz, Francisco Carabantes, M. M. Gordon, A. Jaen, G. Esquerdo, E. Pérez-Ruiz
A sentence under 'Results' heading in the Abstract section was published incorrectly. The correct sentence should read as follows.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8cf2d8bd8dd2721584cbfac7e4e43ca
https://link.springer.com/content/pdf/10.1007/s12094-018-1956-7.pdf
https://link.springer.com/content/pdf/10.1007/s12094-018-1956-7.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jose Luis Perez-Gracia, P. Martín-Duque, G. Amigo, J. Martinez Trufero, M. Lanzuela, G. Esquerdo, A. L. García-Otín, Antonio Antón, R. A. Pazo-Cid
Publikováno v:
Clinical and Translational Oncology. 14:564-574
Angiogenesis is a cornerstone in the process of hepatocarcinogenesis. In the sorafenib era, other antiangiogenic targeted drugs, such as monoclonal antibodies and a new generation of tyrosine kinase inhibitors, have been shown in phase II trials to b
Autor:
J. Zhu, Z. Krzeminski, Štefan Gajdoš, Michael D. Hicks, A. Klotz, B. L. Knight, R. R. Dyvig, Peter Brown, M. Grenon, Yu. N. Krugly, Robert D. Stephens, Walter R. Cooney, Y. Revaz, Jozef Vilagi, P. Scheirich, A. Grauer, Raoul Behrend, Franck Marchis, Lenka Šarounová, Peter Kusnirak, Stefano Mottola, Robert J. Whiteley, Gianluca Masi, G. Burki, Alan W. Harris, Ellen S. Howell, V. Cotrez, C. Demeautis, Jean-Luc Margot, Petr Pravec, N. Waelchli, David J. Tholen, Stephen Larson, Donald P. Pray, Vishnu Reddy, L. Brunetto, S. Moore, P. Thierry, D. Matter, Michael C. Nolan, G. Esquerdo, K. Kirsch, G. M. Funkhouser, G. Kober, G. Hahn, W. Holliday, Brian D. Warner, D. R. Degraff, F. P. Velichko, Adrian Galad, David Higgins, M. Rieugné, Lance A. M. Benner, L. Snyder, R. Roy, S. M. Slivan, N. Kaiser
Publikováno v:
Icarus
Icarus, 2006, 181, pp.63-93. ⟨10.1016/j.icarus.2005.10.014⟩
Icarus, 2006, 181, pp.63-93. ⟨10.1016/j.icarus.2005.10.014⟩
Photometric data on 17 binary near-Earth asteroids (15 of them are certain detections, two are probables) were analysed and characteristic properties of the near-Earth asteroid (NEA) binary population were inferred. We have found that binary systems
Publikováno v:
Icarus
Icarus, Elsevier, 2009, 202 (1), pp.104-118
Icarus, Elsevier, 2009, 202 (1), pp.104-118
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ff8774997c1de15e5380ec6906a46927
https://hal.archives-ouvertes.fr/hal-00463950
https://hal.archives-ouvertes.fr/hal-00463950
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 9(2)
The incidence and prevalence of comorbid conditions in lung cancer patients increase with age. The aim of the study was to determine response and tolerability with the biweekly combination gemcitabine–vinorelbine in elderly non-small-cell lung canc
Autor:
M. Sotelo Lezama, J. Bayo, A. García-Palomo, N. Martínez, A. JaÉn-Morago, J.M. Baena Cañada, M. Fontanillas, G. Esquerdo, M. M. Gordon, J. Salvador Bofill, J.J. Illaramendi, Manuel Ruiz-Borrego, J. Lao, Elisabeth Pérez-Ruiz, Cesar Mendiola, Francisco Carabantes, E. Martinez de Dueñas, I. Blancas, Josefina Cruz, V. Conde Herrero
Publikováno v:
Annals of Oncology. 25:iv120
Aim: After CONFIRM study results, fulvestrant 500 mg (F500) became one of the standard treatments for patients with oestrogen receptor (ER+) Metastatic Breast Cancer (MBC) who previously had progressed on hormonal treatment. The aim of this study is
Autor:
Remei Blanco, Silvia Catot, Oscar Juan, Alfredo Sanchez-Hernandez, Jose Garcia Sanchez, G. Esquerdo, Sonia Maciá, Francisco Aparisi, Francisco Garcia-Pinon, Jose Vidal, J. Garde
Publikováno v:
Journal of Clinical Oncology. 30:e18053-e18053
e18053 Background: CECs play an important role in tumor neovascularisation and may have prognostic value in cancer patients (pts). The objective of this study is to assess the quantification of CECs as a predictor of response to chemotherapy (CT) in